Literature DB >> 3033106

Respiratory burst of normal human eosinophils.

D C Petreccia, W M Nauseef, R A Clark.   

Abstract

Oxidative metabolism of eosinophils has generally been studied in cells from patients with eosinophilia. We isolated eosinophils with purity of greater than 95% from normal donors. Oxygen metabolism of eosinophils and neutrophils was compared using O2-. production as a measure of the stimulus-induced respiratory burst. During 10 min of stimulation, using phorbol myristate acetate (PMA) or opsonized zymosan (OPZ), eosinophils produced two to three times as much O2-. as did neutrophils. Continuous kinetic analysis was used to measure the latency period and maximal rate of O2-. production. Eosinophils has a shorter latency period and greater rate of O2-. production than did neutrophils at all concentrations of PMA. With OPZ stimulation, O2-. production rates by both cells were similar. The latency periods were similar with high concentrations of OPZ but at limiting amounts of OPZ eosinophils had a longer latency period than did neutrophils. In addition, the kinetic assay demonstrated that the respiratory burst in eosinophils was more sustained than in neutrophils. These results indicate substantial differences in the oxidative burst of eosinophils and neutrophils with respect to activation, capacity, and regulation. These distinctive features of O2-. production by eosinophils may be important in host defense against metazoan parasites or in tissue injury during inflammation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033106     DOI: 10.1002/jlb.41.4.283

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

Review 1.  Voltage-gated proton channels: molecular biology, physiology, and pathophysiology of the H(V) family.

Authors:  Thomas E DeCoursey
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

2.  Expression and translocation of Rac2 in eosinophils during superoxide generation.

Authors:  P Lacy; S Mahmudi-Azer; B Bablitz; M Gilchrist; P Fitzharris; D Cheng; S F Man; G M Bokoch; R Moqbel
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

Review 3.  The pathogenesis of endomyocardial fibrosis: the role of the eosinophil.

Authors:  C J Spry
Journal:  Springer Semin Immunopathol       Date:  1989

4.  Interactions between NADPH oxidase-related proton and electron currents in human eosinophils.

Authors:  T E DeCoursey; V V Cherny; A G DeCoursey; W Xu; L L Thomas
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

5.  Uric acid is a major antioxidant in human nasal airway secretions.

Authors:  D B Peden; R Hohman; M E Brown; R T Mason; C Berkebile; H M Fales; M A Kaliner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 6.  The consequences of not having eosinophils.

Authors:  G J Gleich; A D Klion; J J Lee; P F Weller
Journal:  Allergy       Date:  2013-06-06       Impact factor: 13.146

Review 7.  The intimate and controversial relationship between voltage-gated proton channels and the phagocyte NADPH oxidase.

Authors:  Thomas E DeCoursey
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

8.  Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity.

Authors:  M Gziut; H J MacGregor; T G Nevell; T Mason; D Laight; J K Shute
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

9.  Early signalling events implicated in leukotriene B4-induced activation of the NADPH oxidase in eosinophils: role of Ca2+, protein kinase C and phospholipases C and D.

Authors:  R S Perkins; M A Lindsay; P J Barnes; M A Giembycz
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

10.  Temperature dependence of NADPH oxidase in human eosinophils.

Authors:  Deri Morgan; Vladimir V Cherny; Ricardo Murphy; Wei Xu; Larry L Thomas; Thomas E DeCoursey
Journal:  J Physiol       Date:  2003-05-16       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.